Presented for research literature review only Bain MA et al
An advisory panel met last week to consider whether seven popular peptides could move toward federal approval and backed six of them, a step that doesnt put peptides on pharmacy shelves yet, but signals momentum toward wider legal use
It will resume discussion at its next meeting, on September 12
In recent years, the cost of traditional drug development has increased significantly
The exercise intervention resulted in a significantly slower decline of eGFR (calculated using cystatin-C levels) over two years compared with health education alone
doi: 10.1007/s12020-021-02730-0 Summary Keywords growth hormone, insulin-like growth factor, GLP-1RAs, SGLT-2is, diabetes Citation Cignarelli A, Genchi VA, Le Grazie G, Caruso I, Marrano N, Biondi G, DOria R, Sorice GP, Natalicchio A, Perrini S, Laviola L and Giorgino F (2022) Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis